Previous genetic association studies in Chinese populations have revealed that genetic variations in NADPH oxidase genes are linked to RA susceptibility and specific clinical features, with rs4821544 and rs729749 polymorphisms potentially associated with RA risk, further supporting the involvement of the NADPH pathway in RA pathogenesis (39). This evidence concerns the gene FMO5 and rheumatoid arthritis.